Evidence map›Paper›PMID 36283748›Full record

ArticleBMJ open2022

Series of virtual light therapy interventions for fatigue: a feasibility pilot study protocol for a series of personalised (N-of-1) trials.

Mark Butler, Stefani D'Angelo, Courtney Lewis, Danielle Miller, Alexandra Perrin, Jerry Suls, Thevaa Chandereng, Ying Kuen Cheung, Karina W Davidson

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04707846 (Re-engineering Precision Therapeutics Through N-of-1 Trials), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04707846 nacompletednot on this map

Re-engineering Precision Therapeutics Through N-of-1 Trials: Feasibility Study of Personalized Trials of Light Therapy for Fatigue

TypeinterventionalSponsorNorthwell HealthRan2021 to 2022Enrolled60ConditionsFatigueArmsBright Blue Light Commercial AYO Light Therapy Device, Dim Blue Light Commercial AYO Light Therapy Device
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. The N-of-1 Trials and where to use them in Rheumatology.Mediterranean journal of rheumatology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mark ButlerInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA markbutler@northwell.edu.ORCID 0000-0003-4359-2897
Stefani D'AngeloInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Courtney LewisInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Danielle MillerInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Alexandra PerrinInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Jerry SulsInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Thevaa ChanderengMailman School of Public Health, Columbia University, New York, New York, USA.
Ying Kuen CheungMailman School of Public Health, Columbia University, New York, New York, USA.
Karina W DavidsonInstitute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
Northwell Health · USColumbia University · US

Funding

Re-engineering Precision Therapeutics Through N-of-1 TrialsR01LM012836 · NLM · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DAVIDSON, KARINA W. · 2017 to 2023
$7.6M
NLM NIH HHS R01 LM012836
6 · The paper itself

Abstract

introductionFatigue is one of the most commonly recorded patient symptoms that can result in deficits in aspects of psychomotor functioning, cognition, work performance and mood. Research shows that bright light and dim light therapy may be an efficacious way to reduce symptoms of fatigue. Still, the feasibility, scalability, individual treatment effects and adverse event heterogeneity of these treatments are unknown. METHODS AND ANALYSIS: The current study evaluates the feasibility, acceptability and effectiveness of a series of personalised (N-of-1) interventions for virtual delivery of bright light therapy and dim light therapy versus usual care treatment for fatigue in 60 participants. We hypothesise that this study will provide valuable information about implementing virtual, N-of-1 randomised controlled trials (RCTs) for fatigue. It will also offer results about determining participants' ratings of usability and satisfaction with the virtual, personalised intervention delivery system; evaluating participants' improvement of fatigue symptoms; and, in the long term, identify ways to integrate N-of-1 light therapy trials into patient care. ETHICS AND DISSEMINATION: This trial was approved by the Northwell Health Institutional Review Board. The trial results will be published in a peer-reviewed journal. All publications resulting from this series of personalised trials will follow the Consolidated Standards of Reporting Trials extension for N-of-1 trials CENT 2015 reporting guidelines. REGISTRATION DETAILS: This trial is registered in www. CLINICALTRIALS: gov (number NCT04707846). TRIAL REGISTRATION NUMBER: NCT04707846.

Indexed as

FatiguePhototherapyFeasibility StudiesHumansPilot ProjectsRandomized Controlled Trials as TopicBright Light (BL)Dim Light (DL)FatigueFeasibilityLight TherapyN-of-1PersonalisedPersonalised TrialVirtual

Identifiers

PMID36283748
PMCPMC9608534
OpenAlexW4307887895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.